SOMERVILLE, MA--(Marketwire - Jan 5, 2012) - TIBCO Software Inc. (NASDAQ: [ TIBX ]) today announced that Dr. Eskouhie Tchaparian, an independent pharmaceutical consultant, and Ben McGraw, director of life science industry solutions, TIBCO Spotfire®, are hosting a complimentary webcast on Thursday, January 12, 2012 titled "[ Genomic Data Analysis and Drug Discovery ]." The webcast will provide attendees with the knowledge to leverage advanced statistics and dynamic visualizations to get the most biologically relevant results from RT-PCR data.

What/When: "Genomic Data Analysis and Drug Discovery" webcast - Thursday, January 12, 2012 at 11:00 a.m. EST.

In this webcast, Dr. Eskouhie Tchaparian will present her recent publication on the "Effect of Culture Time on the Basal Expression Levels of Drug Transporters in Sandwich-Cultured Primary Rat Hepatocytes." Sandwich-cultured rat hepatocytes are employed in drug discovery for pharmacological and toxicological assessment of drug candidates, yet their utility as a functional model for drug transporters has not been fully characterized. To evaluate the system as an in vitro model for drug transport, expression changes of hepatic transporters relative to whole liver and freshly-isolated hepatocytes (day-0) were examined by RT-qPCR for four consecutive days of culture. The presentation will demonstrate how Integromics® RealTime StatMiner® combined with TIBCO Spotfire can be used to measure relative quantification of transcription levels, to select genes whose expression levels are significantly different between two groups through a step-by-step workflow.

During the webcast, attendees will learn how the RealTime StatMiner software application is specifically designed to enable deeper insights into real-time qPCR data from miRNA and TaqMan arrays, and has helped answer scientific questions using interactive visualizations and advanced statistics allowing for rapid and reliable results.

Information: To register for the webcast, please visit: [ http://spotfire2.tibco.com/l/5772/2011-11-29/2TW0S ].

To learn more about how TIBCO Spotfire's analytics capabilities can empower life science organizations to make smarter business decisions, please visit: [ http://spotfire.tibco.com/spotfire-for-you/by-industry/life-sciences/life-sciences-analytics.aspx ].

About TIBCO
TIBCO Software Inc. (NASDAQ: [ TIBX ]) is a provider of infrastructure software for companies to use on-premise or as part of cloud computing environments. Whether it's efficient claims or trade processing, cross-selling products based on real-time customer behavior, or averting a crisis before it happens, TIBCO provides companies the two-second advantage^™ -- the ability to capture the right information, at the right time and act on it preemptively for a competitive advantage. More than 4,000 customers worldwide rely on TIBCO to manage information, decisions, processes, and applications in real-time. TIBCO Spotfire® is the company's in-memory analytics software for next generation business intelligence. By offering a visual, interactive experience, Spotfire® helps professionals quickly discover new and actionable insights in information. Learn more at [ http://spotfire.tibco.com ].

About Integromics® S.L.
INTEGROMICS S.L. provides IT solutions for Life Sciences in the areas of genomics and proteomics. In the post-genomic era, Integromics S.L. offers state-of-the-art products, services and training in two strategic areas: data management/integration and intelligent data analysis. The company has developed a network of collaborators both in industry and academia to provide complete technological solutions that will help its clients to achieve their goals. Integromics® S.L. was founded in 2002 and is based in Granada, Spain, with offices in Madrid, Spain. Integromics, Inc., a wholly owned subsidiary that was established in 2007, is based Philadelphia, PA. For more information, visit [ http://www.integromics.com ].

TIBCO, TIBCO Software, TIBCO Spotfire, Spotfire, and two-second advantage are trademarks or registered trademarks of TIBCO Software Inc. or its subsidiaries in the United States and/or other countries. All other product and company names and marks mentioned in this document are the property of their respective owners and are mentioned for identification purposes only.